Medpace Voice

In this newly published episode of Seamless Insights: The Podcast, Hamish Baird, President of Remington Davis, sits down with Medpace...

Authors: James Vornov MD, PhD and Jessica Yehnert Recently, the Medpace stroke team attended ISC (International Stroke Conference). Among the many presentations, one study in...

March 4th marks World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...

Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs.

Successfully executing a C-QTc analysis requires the seamless integration of specialized clinical operations, technical ECG expertise, advanced biometrics, and focused reporting. Learn more.

IDWeek 2025 marked a pivotal moment in the evolution of infectious diseases (ID) research and pharmaceutical innovation. Beyond its traditional...

Menopause remains one of the most underrepresented areas in clinical research. Yet this life stage, marked by profound physiological transitions and long-term health implication, presents…

With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development...

With the launch of a newly built, state-of-the-art clinical pharmacology unit, Medpace strengthens its position as a strategic early phase...

Representatives from Medpace’s medical and operational teams engaged in critical discussions around trial innovation, therapeutic advances, and evolving standards of...